drugset / Trial / NCT00986960

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

NCT00986960

Phase 2 Withdrawn University at Buffalo
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate whether the use of ACTH in addition to Avonex is effective in the treatment of relapsing remitting multiple sclerosis.

Timeline

Start
2009-12
Primary completion
2010-09
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acthar Peptide 80 iu Intramuscular

Indications